|
|
|
|
|
|
|
|
|
|
Objectives
As advances in treatment have prolonged survival for many patients with ovarian cancer, there has been growing interest in assessing the adverse effects of disease and treatment. The aim of this study was to review the literature on cognitive function and quality of life (QOL) in this population.
Results
The small number of studies including formal evaluations of neurocognitive function suggests that many ovarian cancer patients experience cognitive difficulties associated with their disease and treatment. Several studies described declines in self-reported cognitive function that may impact QOL, but the results were not consistent across studies.
Highlights
► The literature suggests that many patients with ovarian cancer experience cognitive difficulties associated with their disease and treatment.
► Several studies reported declines in self-reported cognitive function that may impact QOL, but the results were inconsistent across studies.
► Several studies reported declines in self-reported cognitive function that may impact QOL, but the results were inconsistent across studies.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.